These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 27736935)
1. Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease. Wang S; Zhang S; Xu C; Barron A; Galiano F; Patel D; Lee YJ; Caldwell GA; Caldwell KA; Witt SN PLoS One; 2016; 11(10):e0164465. PubMed ID: 27736935 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease. Wang S; Zhang S; Liou LC; Ren Q; Zhang Z; Caldwell GA; Caldwell KA; Witt SN Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E3976-85. PubMed ID: 25201965 [TBL] [Abstract][Full Text] [Related]
3. Impaired biosynthesis of the non-bilayer lipids phosphatidylethanolamine or cardiolipin does not affect peroxisome biogenesis and proliferation in Saccharomyces cerevisiae. Kawałek A; Jagadeesan C; van der Klei IJ Biochem Biophys Res Commun; 2016 Nov; 480(2):228-233. PubMed ID: 27746175 [TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease. Patel D; Xu C; Nagarajan S; Liu Z; Hemphill WO; Shi R; Uversky VN; Caldwell GA; Caldwell KA; Witt SN Hum Mol Genet; 2018 May; 27(9):1514-1532. PubMed ID: 29452354 [TBL] [Abstract][Full Text] [Related]
5. Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae. Joshi AS; Thompson MN; Fei N; Hüttemann M; Greenberg ML J Biol Chem; 2012 May; 287(21):17589-17597. PubMed ID: 22433850 [TBL] [Abstract][Full Text] [Related]
6. Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine and cardiolipin biosynthetic pathways in Saccharomyces cerevisiae. Gohil VM; Thompson MN; Greenberg ML J Biol Chem; 2005 Oct; 280(42):35410-6. PubMed ID: 16036913 [TBL] [Abstract][Full Text] [Related]
8. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714 [TBL] [Abstract][Full Text] [Related]
9. ER-localized phosphatidylethanolamine synthase plays a conserved role in lipid droplet formation. Gok MO; Speer NO; Henne WM; Friedman JR Mol Biol Cell; 2022 Jan; 33(1):ar11. PubMed ID: 34818062 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-associated Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400 [TBL] [Abstract][Full Text] [Related]
11. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease. Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling. Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787 [TBL] [Abstract][Full Text] [Related]
13. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity. Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798 [TBL] [Abstract][Full Text] [Related]
14. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease. Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384 [TBL] [Abstract][Full Text] [Related]
15. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Gitler AD; Bevis BJ; Shorter J; Strathearn KE; Hamamichi S; Su LJ; Caldwell KA; Caldwell GA; Rochet JC; McCaffery JM; Barlowe C; Lindquist S Proc Natl Acad Sci U S A; 2008 Jan; 105(1):145-50. PubMed ID: 18162536 [TBL] [Abstract][Full Text] [Related]
16. α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease. Ryan BJ; Lourenço-Venda LL; Crabtree MJ; Hale AB; Channon KM; Wade-Martins R Free Radic Biol Med; 2014 Feb; 67():58-68. PubMed ID: 24148766 [TBL] [Abstract][Full Text] [Related]
17. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265 [TBL] [Abstract][Full Text] [Related]
18. Deficiency in phosphatidylserine decarboxylase activity in the psd1 psd2 psd3 triple mutant of Arabidopsis affects phosphatidylethanolamine accumulation in mitochondria. Nerlich A; von Orlow M; Rontein D; Hanson AD; Dörmann P Plant Physiol; 2007 Jun; 144(2):904-14. PubMed ID: 17449644 [TBL] [Abstract][Full Text] [Related]
19. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]